Mehta Vimal plan to sell securities of BioXcel Therapeutics, Inc. under Form 144

Mehta Vimal filed Form 144 to notify SEC of plan to sell 19419 units of BioXcel Therapeutics, Inc. securities around 2026-05-20, with aggregate market value of $21,113.72. The total outstanding units is 30877605.0. The amount planned to be sold represents 0.06% of total outstanding units;